| Drug Name |
Prednisolone |
| Drug ID |
BADD_D01831 |
| Description |
Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]
Prednisolone was granted FDA approval on 21 June 1955.[L9431] |
| Indications and Usage |
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542] |
| Marketing Status |
approved; vet_approved |
| ATC Code |
A01AC04; A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02 |
| DrugBank ID |
DB00860
|
| KEGG ID |
D00472
|
| MeSH ID |
D011239
|
| PubChem ID |
5755
|
| TTD Drug ID |
D0D1SG
|
| NDC Product Code |
38779-0150; 64958-0097; 82298-104; 67296-1656; 50383-042; 59651-491; 63187-466; 0527-5406; 65089-0038; 50090-0655; 57582-004; 62135-437; 73534-505; 49452-5980; 82298-105; 82298-106; 60592-911; 60722-3001; 51927-0234; 22552-0052 |
| UNII |
9PHQ9Y1OLM
|
| Synonyms |
Prednisolone | Predate | Predonine | Di-Adreson-F | Di Adreson F | DiAdresonF |
